Yahoo Finance • 9 hours ago
Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its CORIOGRAPH Pre-Op Planning a... Full story
Yahoo Finance • 16 hours ago
In recent trading, shares of Smith & Nephew plc (Symbol: SNN) have crossed above the average analyst 12-month target price of $35.55, changing hands for $36.29/share. When a stock reaches the target an analyst has set, the analyst logical... Full story
Yahoo Finance • 7 days ago
[A magnifying glass placed in the scattered wooden letters] patpitchaya/iStock via Getty Images European MedTech stocks were trading lower on Thursday after the U.S. Department of Commerce launched a new national security investigation in... Full story
Yahoo Finance • 21 days ago
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant and support its further adoption. Substan... Full story
Yahoo Finance • 28 days ago
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the CENTRIO Platelet-Rich-Plasma (PRP) System, a biodynamic hematogel derived from a patient’s own platelets and plasma that, once applie... Full story
Yahoo Finance • last month
Smith & Nephew SNATS Inc (SNN) stock reached a significant milestone by hitting a 52-week high at 37.59 USD. This achievement reflects the company’s robust performance over the past year, marked by a notable 21.78% increase in its stock pr... Full story
Yahoo Finance • last month
Delray Beach, FL, Aug. 22, 2025 (GLOBE NEWSWIRE) -- The global surgical sutures market, valued at US$4.56 billion in 2024, stood at US$4.84 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culmin... Full story
Yahoo Finance • 2 months ago
* Smith & Nephew press release [https://www.smith-nephew.com/en/who-we-are/investors/reports-and-presentations] (NYSE:SNN [https://seekingalpha.com/symbol/SNN]): 1H Non-GAAP EPSA of $0.43. * Revenue of $2.96B (+4.6% Y/Y). H1 underlying... Full story
Yahoo Finance • 2 months ago
We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on Valueinvesting subreddit by KnowledgePatient7813. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc.'s share was trading at $97.55 as... Full story
Yahoo Finance • 2 months ago
Smith & Nephew SNATS Inc (NYSE:SNN) stock reached a 52-week high of 31.72 USD, marking a significant milestone for the company. This achievement reflects a 10.35% increase over the past year, showcasing the company’s positive performance... Full story
Yahoo Finance • 6 months ago
We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Smith & Nephew plc (NYSE:SNN) stands against other most undervalued healthcare stocks... Full story
Yahoo Finance • 7 months ago
Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature the latest advancements in Orthopaedic Reconstruction at the American Academy of Orthopaedic Surgeons Annual Mee... Full story
Yahoo Finance • last year
The London markets have recently experienced declines, with the FTSE 100 index closing lower due to weak trade data from China and a general dip in global economic confidence. Amid these challenging conditions, identifying undervalued stoc... Full story
Yahoo Finance • last year
Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and... Full story
Yahoo Finance • 2 years ago
Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN◊ 3D... Full story
Yahoo Finance • 2 years ago
Insight into the Investment Moves of a Value Investing Stalwart Charles Brandes (Trades, Portfolio), a seasoned value investor and founder of Brandes Investment Partners, has made notable changes to his investment portfolio in the fourth... Full story
Yahoo Finance • 2 years ago
Most readers would already be aware that Smith & Nephew's (LON:SN.) stock increased significantly by 22% over the past three months. However, in this article, we decided to focus on its weak fundamentals, as long-term financial performance... Full story
Yahoo Finance • 2 years ago
Key Insights Smith & Nephew's estimated fair value is UK£17.05 based on 2 Stage Free Cash Flow to Equity Smith & Nephew's UK£10.21 share price signals that it might be 40% undervalued The US$12.68 analyst price target for SN. is 26% less... Full story
Yahoo Finance • 2 years ago
The market rally is going strong, but watch out for a potential pullback. Top stocks near buy points include Boeing and CyberArk.... Full story
Yahoo Finance • 2 years ago
LONDON, May 16, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduces two key products that close the feedback loop for its robotics and digital surgery portfolio – Personalized Plann... Full story